Schedule 13G ownership disclosure

AnaptysBio Inc

Common Stock · CUSIP: 032724106

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Morgan Stanley

    Shares: 1,845,002 · Class: 6.3%

  • Morgan Stanley Capital Services LLC

    Shares: 1,525,502 · Class: 5.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895421-25-000442
Form type
SCHEDULE 13G
Filer
ANAPTYSBIO, INC
CIK
CIK 1370053
Filed
Aug 05, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub